Income statements
for the year ended 30 September 2016
| COMPANY | GROUP | |||||||||||
| 2016 | 2015 Restated*^ |
(R’million) | Notes | 2016 | 2015 Restated*#^ |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Continuing operations | ||||||||||||
| 2 471,0 | 2 235,3 | Revenue | 2 | 31 737,5 | 28 690,1 | |||||||
| Turnover | 3 | 31 697,5 | 28 660,0 | |||||||||
| Cost of sales | (21 498,6) | (18 980,5) | ||||||||||
| Gross profit | 10 198,9 | 9 679,5 | ||||||||||
| Sales and distribution expenses | (3 612,1) | (3 425,7) | ||||||||||
| Marketing expenses | (866,0) | (809,5) | ||||||||||
| (1,8) | 4,6 | Other operating (expenses)/income | (1 566,7) | (1 418,6) | ||||||||
| (1,8) | 4,6 | Operating income/(loss) before impairments and abnormal items | 4 | 4 154,1 | 4 025,7 | |||||||
| – | (678,8) | Impairments | 5 | (334,8) | (319,8) | |||||||
| 1,2 | (106,9) | Abnormal items | 6 | 11,0 | (18,7) | |||||||
| (0,6) | (781,1) | Operating income/(loss) after impairments and abnormal items | 3 830,3 | 3 687,2 | ||||||||
| 110,7 | 123,3 | Net (finance costs)/interest received | 8 | (182,6) | (204,0) | |||||||
| 2 343,4 | 2 099,3 | Investment income | 9 | 6,3 | 0,8 | |||||||
| Income from associated companies | 16 | 860,7 | 602,8 | |||||||||
| 2 453,5 | 1 441,5 | Profit before taxation | 4 514,7 | 4 086,8 | ||||||||
| (48,1) | (42,5) | Taxation | 10 | (1 220,6) | (977,3) | |||||||
| 2 405,4 | 1 399,0 | Profit for the year from continuing operations | 3 294,1 | 3 109,5 | ||||||||
| Discontinued operation | ||||||||||||
| Profit/(loss) for the year from discontinued operation | 35 | 27,6 | (2 167,5) | |||||||||
| Profit for the year | 3 321,7 | 942,0 | ||||||||||
| Attributable to: | ||||||||||||
| 2 405,4 | 1 399,0 | Owners of the parent | 3 305,6 | 1 727,1 | ||||||||
| – Continuing operations | 3 261,2 | 3 121,4 | ||||||||||
| – Discontinued operation | 44,4 | (1 394,3) | ||||||||||
| Non-controlling interests | 16,1 | (785,1) | ||||||||||
| – Continuing operations | 32,9 | (11,9) | ||||||||||
| – Discontinued operation | (16,8) | (773,2) | ||||||||||
| 2 405,4 | 1 399,0 | 3 321,7 | 942,0 | |||||||||
| Basic earnings per ordinary share (cents) | 2 034,4 | 1 068,1 | ||||||||||
| – Continuing operations | 2 007,1 | 1 930,4 | ||||||||||
| – Discontinued operation | 27,3 | (862,3) | ||||||||||
| Diluted basic earnings per ordinary share (cents) | 1 991,5 | 1 050,9 | ||||||||||
| – Continuing operations | 1 964,8 | 1 899,3 | ||||||||||
| – Discontinued operation | 26,7 | (848,4) | ||||||||||
| Headline earnings per share is disclosed in note 11. | ||||||||||||
| * | The comparatives have been restated for the retrospective reclassification relating to the treatment of foreign exchange profits and losses on foreign cash balances and loans of a funding nature previously included in operating income/(loss) and now reclassified to net finance costs. Refer to note 7 for further details. |
| # | Restated as required by IFRS 5 in relation to the treatment of Tiger Branded Consumer Goods plc (TBCG) as a discontinued operation. |
| ^ | Historically, impairments have been disclosed as part of total abnormal items on the face of the income statement with a supporting note specifying the respective detail. For better clarity, impairments are now disclosed separately on the face of the income statement, with the comparative information being restated accordingly. |